Skip to main content

Advertisement

Log in

Management patterns of childhood-onset nephrotic syndrome

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

As an initial effort to identify opportunities to improve the management of children with nephrotic syndrome, the goal of this study was to assess the present-day management of children with primary nephrotic syndrome. A web-based survey was designed to assess the current management styles of all pediatric nephrology faculties at ten participating institutions. Ninety-one percent completed the initial survey. The duration of initial glucocorticoid therapy ranged from 4 to 24 weeks. Physicians reported that the recommendation for kidney biopsy was dependent on the response to initial corticosteroid therapy, with the minority always recommending a biopsy for frequently relapsing or steroid-dependent cases. All responding physicians recommended a kidney biopsy in steroid-resistant cases. Treatment strategies were reported to vary based upon the steroid response pattern and, where available, kidney histopathology. Striking variations in therapeutic preferences were described when alternatives to glucocorticoids were considered. The variability of management practices among pediatric nephrologists in the USA combined with the changing characteristics of our pediatric population raise concerns about our future strategies for improving healthcare for children coping with nephrotic syndrome. This variability is not unique to children’s healthcare or to nephrology. However, a systematic approach to patient care and improvement in health outcomes has been shown to substantially improve morbidity and mortality outcomes in children with chronic health conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Report of the International Study of Kidney Disease in Children (1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 98:561–564

    Article  Google Scholar 

  2. Churg J, Habib R, White RH (1970) Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet 760:1299–1302

    Article  CAS  PubMed  Google Scholar 

  3. Ehrich JH, Brodehl J (1993) Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Eur J Pediatr 152:357–361

    Article  CAS  PubMed  Google Scholar 

  4. Arbeitsgemeinschaft für Pädiatrische Nephrologie (1979) Alternate-day versus intermittent prednisone in frequently relapsing nephrotic syndrome. A report of Arbeitsgemeinschaft für Pädiatrische Nephrologie. Lancet 1:401–403

    Google Scholar 

  5. Arbeitsgemeinschaft für Pädiatrische Nephrologie (1988) Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie. Lancet 1:380–383

    Google Scholar 

  6. Sorof JM, Hawkins EP, Brewer ED, Boydstum II, Kale AS, Powell DR (1998) Age and ethnicity affect the risk and outcome of focal segmental glomerulosclerosis. Pediatr Nephrol 12:764–768

    Article  CAS  PubMed  Google Scholar 

  7. Valeri A, Barisoni L, Appel GB, Seigle R, D‘Agati V (1996) Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study. Kidney Int 50:1734–1746

    Article  CAS  PubMed  Google Scholar 

  8. Ingulli E, Tejani A (1991) Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children. Pediatr Nephrol 5:393–397

    Article  CAS  PubMed  Google Scholar 

  9. Borges FF, Shiraichi L, da Silva MP, Nishimoto EI, Noqueira PC (2007) Is focal segmental glomerulosclerosis increasing in patients with nephrotic syndrome? Pediatr Nephrol 22:1309–1313

    Article  PubMed  Google Scholar 

  10. Lichtig C, Ben-Izhak O, On A, Levy J, Allon U (1991) Childhood minimal change disease and focal segmental glomerulosclerosis: a continuous spectrum of disease? Pathologic study of 33 cases with long-term follow-up. Am J Nephrol 11:325–331

    Article  CAS  PubMed  Google Scholar 

  11. Harris KM, Gordon-Larsen P, Chantala K, Udry JR (2006) Longitudinal trends in race/ethnic disparities in leading health indicators from adolescence to young adulthood. Arch Pediatr Adolesc Med 160:74–81

    Article  PubMed  Google Scholar 

  12. Fagot-Campagna A, Pettitt DJ, Engelgau MM, Burrows NR, Geiss LS, Valdez R, Beckles GL, Saaddine J, Gregg EW, Williamson DF, Narayan KM (2000) Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 136:664–672

    Article  CAS  PubMed  Google Scholar 

  13. Hiraoka M, Tsukahara H, Matsubara K, Tsurusawa M, Takeda N, Haruki S, Hayashi S, Ohta K, Momoi T, Ohshima Y, Suganuma N, Mayumi M (2003) A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children. Am J Kidney Dis 41:1155–1162

    Article  CAS  PubMed  Google Scholar 

  14. Hodson EM, Knight JF, Willis NS, Craig JC (2007) Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev CD001533

  15. Abeyagunawardena AS, Dillon MJ, Rees L, van’t Hoff W, Trompeter RS (2003) The use of steroid-sparing agents in steroid-sensitive nephrotic syndrome. Pediatr Nephrol 18:919–924

    Article  PubMed  Google Scholar 

  16. Gregory MJ, Smoyer WE, Sedman A, Kershaw DB, Valentini RP, Johnson K, Bunchman TE (1996) Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis. J Am Soc Nephrol 7:543–549

    CAS  PubMed  Google Scholar 

  17. Hulton SA, Jadresic L, Shah V, Trompeter RS, Dillon MJ, Barratt TM (1994) Effect of cyclosporin A on glomerular filtration rate in children with minimal change nephrotic syndrome. Pediatr Nephrol 8:404–407

    Article  CAS  PubMed  Google Scholar 

  18. Latta K, von Schnakenburg C, Ehrich JH (2001) A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 16:271–282

    Article  CAS  PubMed  Google Scholar 

  19. Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D’Agati VD (2003) C1q nephropathy: a variant of focal segmental glomerulosclerosis. Kidney Int 64:1232–1240

    Article  CAS  PubMed  Google Scholar 

  20. Jennette JC, Hipp CG (1985) C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis 6:103–110

    Article  CAS  PubMed  Google Scholar 

  21. Lande MB, Leonard MB (2000) Variability among pediatric nephrologists in the initial therapy of nephrotic syndrome. Pediatr Nephrol 14:766–769

    Article  CAS  PubMed  Google Scholar 

  22. Davis PB (2006) Cystic fibrosis since 1938. Am J Respir Crit Care Med 173:475–482

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Debbie S. Gipson.

Additional information

Funding

This research was supported in part by the UNC Center for Education and Research on Therapeutics (Stiles, PI), funded by the Agency for Healthcare Research and Quality, award number 2 U18HS10397-08.

Rights and permissions

Reprints and permissions

About this article

Cite this article

MacHardy, N., Miles, P.V., Massengill, S.F. et al. Management patterns of childhood-onset nephrotic syndrome. Pediatr Nephrol 24, 2193–2201 (2009). https://doi.org/10.1007/s00467-009-1282-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-009-1282-y

Keywords

Navigation